BrainsWay to Report Fourth Quarter and Full Year 2025 Financial Results on March 11, 2026

Core Viewpoint - BrainsWay Ltd. will report its fourth quarter and full year 2025 financial results on March 11, 2026, and will host a conference call to discuss these results and provide updates on business operations [1]. Group 1: Financial Reporting - The financial results will be announced before the U.S. financial markets open on March 11, 2026 [1]. - A conference call and webcast will take place at 8:30 AM Eastern Time to discuss the results [1]. Group 2: Conference Call Details - The conference call can be accessed in the U.S. at 1-877-300-8521 and internationally at 1-412-317-6026 [2]. - The conference ID for the call is 10206784, and it will be available for replay for 30 days on the Company's website [2]. Group 3: Company Overview - BrainsWay is a leader in noninvasive neurostimulation treatments for mental health disorders, utilizing its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS™) technology [3]. - The company has obtained three FDA-cleared indications for its treatments, including major depressive disorder, obsessive-compulsive disorder, and smoking addiction [3]. - Founded in 2003, BrainsWay operates in the U.S. and Israel and is focused on increasing awareness and access to Deep TMS [3].